A plasma microRNA panel for early detection of colorectal cancer: Plasma microRNA and Colorectal Cancer
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Colonoscopy remains the standard screening method for detecting colorectal cancer (CRC) at an early stage. However, many people avoid having a colonoscopy because of the fear for its potential complications. Our study aimed to identify plasma microRNAs for preliminarily screening CRC in general population, so that some unnecessary colonoscopies can be avoided. We investigated plasma microRNA expression in three independent cohorts including the discovery (n = 80), training (n = 112), and validation (n = 49) phases recruited at two medical centers. Microarrays were used for screening 723 microRNAs in 80 plasma samples to identify candidate microRNAs. Quantitative reverse-transcriptase PCR was performed on the 161 training and validation plasma samples to evaluate the candidate microRNAs discovered from microarrays. A logistic regression model was constructed based on the training cohort and then verified by using the validation dataset. Area under the receiver operating characteristic curve (AUC) was used to evaluate the diagnostic accuracy. We identified a panel of miR-409-3p, miR-7, and miR-93 that yielded high diagnostic accuracy in discriminating CRC from healthy group (AUC: 0.866 and 0.897 for training and validation dataset, respectively). Moreover, the diagnostic performance of the microRNA panel persisted in nonmetastasis CRC stages (Dukes' A-B, AUC: 0.809 and 0.892 for training and validation dataset, respectively) and in metastasis CRC stages (Dukes' C-D, AUC: 0.917 and 0.865 for training and validation dataset, respectively). In conclusion, our study reveals a plasma microRNA panel that has potential clinical value in early CRC detection and would play a critical role on preliminarily screening CRC in general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679 · cited 2×
“Colorectal cancer (CRC) is the fourth most common cancer and the fourth leading cause of cancer deaths in the world.(1) An estimated 1.”
BackgroundDeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303 · cited 1×
“Following the guidelines on the minimum information for publication of quantitative real-time PCR experiments (MIQE).(30) The Taqman MicroRNA assays were first performed on 112 plasma samples for eight candidate microRNAs (miR-25, miR-331-3p, miR-345, miR-409-3p, miR-671-3p, miR-7, miR-92a, and miR-93).”
MethodOn a Test of Whether one of Two Random Variables is Stochastically Larger than the Other
Mann, H. B., & Whitney, D. R. (1947) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177730491 · Cited by 14,320
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Self-citationmiRBase: integrating microRNA annotation and deep-sequencing data
Kozomara, A., & Griffiths-Jones, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1027 · Cited by 3,634 · cited 1×
“The microarray contains probes for 723 human microRNAs from miRBase.(28) Each slide is formatted with eight identical arrays.”
MethodRandomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,793
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
World Health Organization classification of tumors
Kleihues, P., & Sobin, L. H. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2887::aid-cncr32>3.0.co;2-f · Cited by 2,377
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,775
Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. W., Au, G. K. H., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,578
The classification of cancer of the rectum
Dukes, C. E. (1932) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700350303 · Cited by 1,505
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
Mandel, J. S., Church, T. R., Bond, J. H., Ederer, F., Geisser, M. S., Mongin, S. J., Snover, D. C., & Schuman, L. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432203 · Cited by 1,423 · cited 1×
“On the other hand, the FOBT is a simple and cheap test, but it has less than ideal clinical specificity.(14) CEA has been used for many years as a serum marker for CRC screening and prognosis.”
BackgroundNg, E. K. O., Chong, W. W. S., Jin, H., Lam, E. K. Y., Shin, V. Y., Yu, J., Poon, T. C. W., Ng, S. S. M., & Sung, J. J. Y. (2009) · Gut · doi:10.1136/gut.2008.167817 · Cited by 1,151 · cited 1×
“Ng et al.(23) found the significantly elevated expression level of miR92 in the plasma of patients with CRC.”
BackgroundPlasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W., & Du, X. (2010) · International Journal of Cancer · doi:10.1002/ijc.25007 · Cited by 964 · cited 2×
“In addition, Huang et al.24 found that miR-29a and miR-92a were significantly elevated in the CRC plasma samples when compared with normal controls.”
BackgroundBandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramírez, N., Abajo, A., Navarro, A., Moreno, I., Monzó, M., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-29 · Cited by 892
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
Duffy, M. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.624 · Cited by 794
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., Wang, J.-F., Zhang, Z., Lu, S., Huang, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2697 · Cited by 635 · cited 1×
“The raw signals obtained for single-color CY3 hybridization were normalized by a stable endogenous control miR-1228.(29) Then a log transform with base 2 was performed.”
MethodSelf-citationPatterns and predictors of colorectal cancer test use in the adult U.S. population
Seeff, L. C., Nadel, M. R., Klabunde, C. N., Thompson, T., Shapiro, J. A., Vernon, S. W., & Coates, R. J. (2004) · Cancer · doi:10.1002/cncr.20276 · Cited by 538
Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
Schepeler, T., Reinert, J. T., Ostenfeld, M. S., Christensen, L. L., Silahtaroglu, A. N., Dyrskjøt, L., Wiuf, C., Sørensen, F. J., Kruhøffer, M., Laurberg, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6110 · Cited by 492
Cheng, H., Zhang, L., Cogdell, D. E., Zheng, H., Schetter, A. J., Nykter, M., Harris, C. C., Chen, K., Hamilton, S. R., & Zhang, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017745 · Cited by 430 · cited 1×
“Nevertheless, another study found that miR-92a dramatically decreased in the plasma of patients with acute leukemia.(25) Moreover, none of the three significant microRNAs in our predictive panel has been reported in the serum or plasma of patients with CRC.”
ResultPathology and genetics of tumors of the digestive system
Yajnik, V. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)70019-4 · Cited by 384
Factors associated with colon cancer screening: the role of patient factors and physician counseling
Wee, C. C., McCarthy, E. P., & Phillips, R. S. (2005) · Preventive Medicine · doi:10.1016/j.ypmed.2004.11.004 · Cited by 299
Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy
Nelson, D. B., & Muscarella, L. F. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i25.3953 · Cited by 152 · cited 1×
“Concerns on the potential complications and costs in an invasive procedure further decrease the success of screening colonoscopy.(9,10) In contrast, the flexible sigmoidoscopy has a relatively low cost and is less invasive for early detection of neoplasia in the distal colon and Key words: colorectal cancer, colorecta…”
BackgroundSharaf, R., & Ladabaum, U. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.380 · Cited by 137 · cited 1×
“However, recent studies demonstrated that the sigmoidoscopic screening failed to detect a substantial proportion of asymptomatic neoplasia due to its inability in delivering 50% protection against CRC in the proximal colon.(43) Similarly, the sigmoidoscopy is not suitable for screening CRC in general population.”
ResultZheng, B., Liang, L., Huang, S., Zha, R., Liu, L., Jia, D., Tian, Q., Wang, Q., Wang, C. M., Long, Z., et al. (2011) · Oncogene · doi:10.1038/onc.2011.581 · Cited by 133 · cited 1×
“MicroRNA-409-3p was reported to be significantly downregulated in gastric cancer cell lines and tissues.(49,50) It suppressed tumor cell invasion and metastasis by directly targeting radixin(49) and suppressed cell proliferation and induced cell apoptosis by targeting PHF10.”
BackgroundScreening behavior of individuals at high risk for colorectal cancer
Bleiker, E. M. A., Menko, F. H., Taal, B. G., Kluijt, I., Wever, L. D. V., Gerritsma, M. A., Vasen, H. F. A., & Aaronson, N. K. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.002 · Cited by 127
The structure, metabolism and function of the carcinoembryonic antigen gene family
Thomas, P., TOTH, C. A., Saini, K. S., Jessup, J. M., & Steele, G. D. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90003-j · Cited by 117 · cited 1×
“CEA has been used for many years as a serum marker for CRC screening and prognosis.(15,16) However, CEA test has relatively low sensitivity and specificity which make it unsuitable for screening large asymptomatic patients.”
MethodBond, J. (2001) · Endoscopy · doi:10.1055/s-2001-11185 · Cited by 98
Yang, I., Tsai, H., Hou, M., Chen, K., Tsai, P., Huang, S., Chou, W., Wang, J., & Juo, S. H. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs166 · Cited by 94
Self-citationMicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer
Li, C., Nie, H., Wang, M., Su, L., Li, J., Yu, B., Wei, M., Ju, J., Yu, Y., Yan, M., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.030 · Cited by 90 · cited 3×
“In our previous studies, we showed that miR-7 had increased in the expression level with the adenoma to carcinoma transition.46 It strongly expressed in the epithelial cells of colorectal tissues.47 Further functional study is needed to confirm the role of miR-7 in CRC. Recently, it was reported that miR-93 had substa…”
BackgroundBond, J. H. (2003) · Endoscopy · doi:10.1055/s-2003-36410 · Cited by 72
Wang, S., Wang, L., Zhu, T., Gao, X. J., Li, J., Wu, Y., & Zhu, H. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-163 · Cited by 63 · cited 1×
“It strongly expressed in the epithelial cells of colorectal tissues.(47) Further functional study is needed to confirm the role of miR-7 in CRC.”
BackgroundSelf-citationLittlejohn, C., Hilton, S., Macfarlane, G. J., & Phull, P. S. (2012) · British journal of surgery · doi:10.1002/bjs.8882 · Cited by 59 · cited 1×
“rectum, however, the sigmoidoscopy is not able to view the entire colon.(11) Double-contrast BE is radiological technique that can be used for CRC screening in general population.”
MethodGlick, S. N. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.6.1741529 · Cited by 57 · cited 1×
“However, reports in the clinical literature commonly diminish its value due to the facts that it is not as accurate as colonoscopy and cannot perform biopsy.(12) Also like doublecontrast BE, CT colonography has been included in the screening guidelines, but it has not been widely used for colon cancer screening.”
BackgroundPsychosocial factors associated with the adherence to a colorectal cancer screening program
Gili, M., Roca, M., Pérez, V. A. F., Obrador, A., & Cabeza, E. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.06.005 · Cited by 56
Review article: population screening for colorectal cancer
Nicholson, F. B., Barro, J. L., Atkin, W. S., Lilford, R. J., Patnick, J., Williams, C. B., Pignone, M. P., Steele, R. J., & Kamm, M. A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02695.x · Cited by 50
Wang, S., Wang, L., Bayaxi, N., Li, J., Verhaegh, W., Janevski, A., Varadan, V., Ren, Y., Merkle, D., Meng, X., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301554 · Cited by 37 · cited 1×
“In our previous studies, we showed that miR-7 had increased in the expression level with the adenoma to carcinoma transition.(46) It strongly expressed in the epithelial cells of colorectal tissues.”
BackgroundSelf-citation
Cited by
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 969
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer
Cekaite, L., Eide, P. W., Lind, G. E., Skotheim, R. I., & Lothe, R. A. (2016) · Oncotarget · doi:10.18632/oncotarget.6390 · Cited by 84
Metadata
- Authors
- Wang, S., Xiang, J., Li, Z., Lu, S., Hu, J., Gao, X., Yu, L., Wang, L., Wang, J., Wu, Y., Chen, Z., & Zhu, H.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2014-04-25
- Volume
- 136
- Issue
- 1
- Pages
- 152-161
- ISSN
- 0020-7136 (ISSN-L)
- OpenAlex
- W1766127718
- Cited by
- 162
- References
- 41
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.